JCR Pharmaceuticals Co., Ltd. (JP:4552) has released an update.
JCR Pharmaceuticals Co., Ltd. has completed the payment for the disposition of treasury stock, using it as restricted stock compensation for directors, executive officers, employees, and subsidiary directors, totaling 663,500 shares at 625 yen per share. This move aligns with the company’s commitment to growth and global expansion in rare and genetic disease treatment. JCR continues to leverage its scientific expertise to develop next-generation therapies for a range of conditions.
For further insights into JP:4552 stock, check out TipRanks’ Stock Analysis page.
